|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
1996-12-13
|
|
pubmed:abstractText |
To determine whether patients with primary Sjögren's syndrome (SS), diagnosed according to San Diego criteria, had improvement in their laboratory or clinical features during treatment with hydroxychloroquine (6-7 mg/kg/day) for at least two years.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0961-2033
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
5 Suppl 1
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
S31-6
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:8803908-Adolescent,
pubmed-meshheading:8803908-Adult,
pubmed-meshheading:8803908-Aged,
pubmed-meshheading:8803908-Antimalarials,
pubmed-meshheading:8803908-Antirheumatic Agents,
pubmed-meshheading:8803908-Child,
pubmed-meshheading:8803908-Female,
pubmed-meshheading:8803908-Humans,
pubmed-meshheading:8803908-Hydroxychloroquine,
pubmed-meshheading:8803908-Keratoconjunctivitis Sicca,
pubmed-meshheading:8803908-Male,
pubmed-meshheading:8803908-Middle Aged,
pubmed-meshheading:8803908-Retrospective Studies,
pubmed-meshheading:8803908-Sjogren's Syndrome,
pubmed-meshheading:8803908-Xerostomia
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.
|
|
pubmed:affiliation |
Division of Rheumatology, Scripps Clinic and Research Foundation, La Jolla, CA 92037, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.
|
